Alzheimer Biomarkers Higher in Women - Summary - MDSpire

Alzheimer Biomarkers Higher in Women

  • By

  • Kathryn Wighton

  • January 30, 2026

  • 3 min

Share

Objective:

To investigate sex differences in Alzheimer pathology and structural brain resilience in a community-based cohort of adults without cognitive impairment.

Approach:
    Key Findings:
    • Women exhibited higher global amyloid burden than men.
    • Women had greater tau burden in advanced Braak stages compared to men.
    • Women showed greater Alzheimer disease signature cortical thickness and lower white matter hyperintensity burden than men.
    • Sex differences in tau burden were more pronounced among apolipoprotein E epsilon 4 carriers.
    Interpretation:

    The findings suggest that women may have a unique profile of Alzheimer pathology characterized by higher amyloid and tau levels, alongside structural resilience in certain brain regions.

    Limitations:
    • Cross-sectional design limits causal inference.
    • Sex determined by self-report may introduce misclassification.
    • Lack of assessment for gender-related sociocultural factors.
    • Sample unevenly distributed by sex and racial/ethnic subgroups.
    Conclusion:

    Further research with larger, more balanced cohorts is needed to explore the intersection of sex, race, and ethnicity in Alzheimer disease outcomes.

    Sources:

Original Source(s)

Related Content